119 results found.
          
Stryker Reports 3Q15 Revenue: Hips and Knees +3%, Spine +2% CC
Stryker reported 3Q15 orthopaedic revenue of US $1,393.6MM, -0.3% from 3Q14 on an as-reported basis.
CONMED Reports 3Q15 Revenue
CONMED reported 3Q15 orthopaedic revenue of US $89.4MM, -3.6% as reported and +1.4% in constant currency.
BARE BONES® - July 23, 2015
Stryker posted 2Q15 net sales of US $2,432MM, +7.6% from 2Q14. (Ortho $1,035MM, +6.2%: Hips $320MM, +3.7%, Knees $346MM, +3.6%, Trauma/Extremities $309MM, +10.8%, Other
BARE BONES® - April 21, 2015
Stryker reported 1Q15 net sales of US $2,379MM, +7.4% from 1Q14. (Orthopaedics $1,023MM, +7.5%: Hips $312MM, +3.6%, Knees $345MM, +3.1%, Trauma/Extremities $313MM, +15%; Other...
BARE BONES® - January 27, 2015
Stryker posted net sales for 4Q14 of US $2,618MM, +8.6% from 4Q13, and 2014 of $9,675MM, +8.3% from 2013. (2014 Orthopaedics $4,153MM, +6.3%: Hips $1,291MM, +2.7%
2014 Revenue: Stryker
4Q14 revenue: Orthopaedics $1,110MM, +5% (U.S. +7%) Hips $331MM, +0.1% (U.S. +5%, ex-U.S. -5%) Knees $363MM, flat (U.S. flat) Trauma/Extremities $335MM, +13% (U.S. +19%; U.S. Foot/Ankle +25%) Other $81MM, +13%...
BARE BONES® - January 14, 2015
Stryker posted 4Q14 and 2014 preliminary sales of US $2.6BB, +8.6% from 4Q13 and $9.7BB, +8.3% from 2013, respectively. (2014 Orthopaedics $4.2BB, +6.3%; MedSurg $3.8BB, +11.7%
3Q14 Revenue: Bacterin
$8.4MM, +7% OsteoSponge bone void filler represents ~60% of trailing revenue, OsteoSelect DBM putty ~17% In early 4Q, launched 3Demin (demineralized) line for procedures requiring larger volume of bone graft; Boat and Strip configurations targeted for complex...
BARE BONES® - October 16, 2014
Stryker posted 3Q14 net sales of US $2,389MM, +11.3% from 3Q13. (Reconstructive $1,016MM, +8.6%: Hips $316MM, +4.1%, Knees $335MM, +6.4%, Trauma/Extremities $309MM, +11.9%; Me...
3Q14 Revenue: Stryker
$2,389MM, +11% (U.S. $1,628MM, +12%; ex-U.S. $761MM, +9%: China >20%) Reconstructive $1,016MM, +9% (U.S. +12%, ex-U.S. +4%) Hips $316MM, +4% (U.S. +8%, ex-U.S. -1%) Knees $335MM, +6% (U.S. +7%, ex-U.S. +5%) Trauma/Extremities $309MM,...
2Q14 Revenue: Symmetry Medical
$101.3MM, +2.3% Instruments $29.8MM, +6% Implants $29.4MM, +5% Cases $17.3MM, +1% Other $4.4MM, +29% Surgical $20.4MM, -9%   Announced proposed sale of OEM Solutions business...
BARE BONES® - July 17, 2014
Stryker posted 2Q14 net sales of US $2,363MM, +6.9% from 2Q13. (Reconstructive $1,028MM, +6.3%: Hips $326MM, +2.2%, Knees $350MM, +2.7%, Trauma/Extremities $298MM, +11.3%; Med...
BARE BONES® - April 23, 2014
Stryker reported 1Q14 net sales of US $2,305MM, +5% from 1Q13. (Reconstructive $999MM, +5.9%: Hips $318MM, +4.9%, Knees $348MM, +2.3%, Trauma/Extremities $288MM, +9.4%; Neurot...
1Q14 Revenue: Stryker
$2,305MM, +5% (U.S. $1,542MM, +7; ex-U.S. $763MM, +5%) Reconstructive $999MM, +6% (U.S. +8%, ex-U.S. +3%) Hips $318MM, +5% (U.S. +6%, ex-U.S. +4%) Knees $348MM, +2% (U.S. +4%, ex-U.S. -2%) Trauma/Extremities $288MM, +9% (U.S. +12%, e...
Arthroscopy/Soft Tissue Repair Market Exceeds $4.5 Billion
The arthroscopy and soft tissue repair market topped an estimated $4.5 billion in 2013, an increase of seven percent from 2012. The market is expected to experience high single-digit growth in each of the next five years, remaining among the healthier segments in the orthopaedic industry.
4Q13/2013 Revenue: Smith & Nephew
4Q13 Advanced Surgical Devices revenue: $818MM, +5% (U.S. $382MM, +6%, Established ex-U.S. Markets $318MM, flat; Emerging & International $118MM, +16%) Hips $175MM, +2% (U.S. flat, ex-U.S. +4%) Knees $236MM, +5% (U.S. +11%, ex-U.S. -2%) Sports ...
BARE BONES® - January 22, 2014
Stryker posted 4Q13 net sales of US $2,468MM, +5.6% from 4Q12, and 2013 net sales of $9,021MM, +4.2% from 2012 (2013 Recon $4,004MM, +6.9%: Hips $1,272MM, +6%, Knees $...
4Q13/2013 Revenue: Stryker
4Q13 revenue: $2,468MM, +6% (U.S. $1,636MM, +7%; ex-U.S. $832MM, +8%) Recon $1,107MM, +8% (U.S. +9%, ex-U.S. +7%) Hips $341MM, +8% (U.S. +10%, ex-U.S. +6%) Knees $371MM, +5% (U.S. +8%, ex-U.S. -2%) Trauma/Extremities $307MM,...
BARE BONES® - October 17, 2013
Stryker posted 3Q13 net sales of US $2,151MM, +6.8% from 3Q12. (U.S. $1,449MM, +6.5%, ex-U.S. $702MM, +7.5%; Reconstructive $949MM, +9.2%: Hips $304MM, +9.3%,...
3Q13 Revenue: Stryker
$2,151MM, +7% (U.S. $1,449MM, +7%, ex-U.S. $702MM, +8%) Reconstructive $949MM, +9% (U.S. +10%, ex-U.S. +8%) Hips $304MM, +9% (U.S. +9%, ex-U.S. +9%) Knees $315MM, +2% (U.S. +4%, e...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - July 18, 2013
Stryker posted 2Q13 net sales of US $2,212MM, +5.9% from 2Q12. (Reconstructive $979MM, +7.6%: Hips $319MM, +6%, Knees $340MM, +4.7%, Trauma/Extremities $266MM, +17%; MedSurg E...
2Q13 Revenue: Stryker
$2,212MM, +6% (U.S. $1,458MM, +5%; ex-U.S. $754MM, +9%; Trauson +2%) Reconstructive $979MM, +8% (U.S. +6%, ex-U.S. +9%) Hips $319MM, +6% (U.S. +6%, ex-U.S. +6%) Knees $340MM, +5% (U.S. +2%, ex-U.S. +10%) Trauma/Extremities $266MM, +1...
BARE BONES® - April 24, 2013
Stryker reported 1Q13 net sales of US $2,190MM, +2.5% from 1Q12. (U.S. $1,441MM, +4%, ex-U.S. $749MM, +0.2%; Reconstructive $969MM, +2.8%; Neurotechnology/Spine $397MM, +5.5%;...
1Q13 Revenue: Stryker
$2,190MM, +3% (U.S. $1,441MM, +4%, ex-U.S. $749MM, +0.2%) Reconstructive $969MM, +3% (U.S. +7%, ex-U.S. -2%) Hips $308MM, +1% (U.S. +4%, ex-U.S. -2%) Knees $345MM, -1% (U.S. -0.4%, ex-U.S. -2%) Trauma/Extremities $266MM, +12% (U.S. +...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group